Stem cell transplant and Atypical mycobacterial infection

Summary:

Atypical mycobacterial infection is found among people with Stem cell transplant, especially for people who are male, 60+ old.

The study analyzes which people have Atypical mycobacterial infection with Stem cell transplant. It is created by eHealthMe based on reports of 11 people who have Stem cell transplant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Stem cell transplant?

Stem cell transplant is found to be associated with 431 drugs and 384 conditions by eHealthMe. Check the latest studies of Stem cell transplant.

What is Atypical mycobacterial infection?

Atypical mycobacterial infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis) is found to be associated with 136 drugs and 492 conditions by eHealthMe. Check the latest studies of Atypical mycobacterial infection.



On Jul, 28, 2026

11 people who have Stem Cell Transplant and Atypical Mycobacterial Infection are studied.

Would you have Atypical mycobacterial infection when you have Stem cell transplant?

Gender of people who have Stem Cell Transplant and experienced Atypical Mycobacterial Infection *:

  • female: 20 %
  • male: 80 %

Age of people who have Stem Cell Transplant and experienced Atypical Mycobacterial Infection *:

  • 0-1: 9.09 %
  • 2-9: 0.0 %
  • 10-19: 27.27 %
  • 20-29: 27.27 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 36.36 %

Common co-existing conditions for these people *:

  1. Bone Marrow Conditioning Regimen: 2 people, 18.18%
  2. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 9.09%

Common drugs taken by these people *:

  1. Prednisolone: 3 people, 27.27%
  2. Prograf: 2 people, 18.18%
  3. Plerixafor: 2 people, 18.18%
  4. Tepadina: 1 person, 9.09%
  5. Fludarabine Phosphate: 1 person, 9.09%
  6. Fludara: 1 person, 9.09%
  7. Cytoxan: 1 person, 9.09%
  8. Busulfex: 1 person, 9.09%

Common symptoms for these people *:

  1. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 5 people, 45.45%
  2. Pneumonia Bacterial (pneumonia associated with bacterial infection): 3 people, 27.27%
  3. Cryptogenic Organizing Pneumonia (small airways (bronchioles) and air exchange sac (alveoli) become inflamed with connective tissue): 3 people, 27.27%
  4. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 27.27%
  5. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 18.18%
  6. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 2 people, 18.18%
  7. Obliterative Bronchiolitis (bronchiolar inflammation): 2 people, 18.18%
  8. Leukaemia Recurrent (repeat cancer of bone marrow or blood cells): 2 people, 18.18%
  9. Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 18.18%
  10. Transplant Failure (transplantation failed to meet outcome): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Atypical mycobacterial infection?

- Check whether Atypical mycobacterial infection is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Atypical mycobacterial infection:

All the conditions that are associated with Atypical mycobacterial infection:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Atypical mycobacterial infection and Stem cell transplant, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: